These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Neal DA; Gimson AE; Gibbs P; Alexander GJ Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583 [TBL] [Abstract][Full Text] [Related]
3. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation. Ramos-Cebrián M; Torregrosa JV; Gutiérrez-Dalmau A; Oppenheimer F; Campistol JM Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154 [TBL] [Abstract][Full Text] [Related]
4. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors. Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397 [TBL] [Abstract][Full Text] [Related]
5. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children. Tumgor G; Arikan C; Kilic M; Aydogdu S Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488 [TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339 [TBL] [Abstract][Full Text] [Related]
7. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation. Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209 [TBL] [Abstract][Full Text] [Related]